New combo tackles tough brain cancer spread in lung patients
NCT ID NCT07398599
First seen Feb 15, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study tests a combination of higher-dose targeted therapy, an anti-angiogenesis drug, and chemotherapy injected into the spine for people with advanced lung cancer that has spread to the lining of the brain and is no longer responding to standard treatment. About 30 adults with specific gene mutations will receive this regimen to see if it shrinks the brain tumors and to track any side effects. The goal is to better control the disease, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, China
Conditions
Explore the condition pages connected to this study.